| Patent | Date |
|---|
Ophthalmic Formulations Of Cetirizine And Methods Of Use
App 20210290617 - ABELSON; Mark Barry ; et al. | 2021-09-23 |
Ophthalmic formulations of cetirizine and methods of use
Grant 10,987,352 - Abelson , et al. April 27, 2 | 2021-04-27 |
Ophthalmic Formulations Of Cetirizine And Methods Of Use
App 20200405711 - ABELSON; Mark Barry ; et al. | 2020-12-31 |
Ophthalmic Formulations Of Cetirizine And Methods Of Use
App 20200297719 - ABELSON; Mark Barry ; et al. | 2020-09-24 |
Ophthalmic formulations of cetirizine and methods of use
Grant 10,675,279 - Abelson , et al. | 2020-06-09 |
Ophthalmic Formulations Of Cetirizine And Methods Of Use
App 20180280383 - ABELSON; Mark Barry ; et al. | 2018-10-04 |
Ophthalmic formulations of cetirizine and methods of use
Grant 9,993,471 - Abelson , et al. June 12, 2 | 2018-06-12 |
Topical Ophthalmic Formulations For The Treatment And Prevention Of Migraine Headache
App 20180140612 - Abelson; Mark B. ; et al. | 2018-05-24 |
Ophthalmic formulations of cetirizine and methods of use
Grant 9,750,684 - Abelson , et al. September 5, 2 | 2017-09-05 |
Ophthalmic Formulations Of Cetirizine And Methods Of Use
App 20170182035 - Abelson; Mark Barry ; et al. | 2017-06-29 |
Topical Ophthalmic Formulations for the Treatment and Prevention of Migraine Headache
App 20170042903 - Abelson; Mark B. ; et al. | 2017-02-16 |
Ophthalmic Formulations Of Cetirizine And Methods Of Use
App 20160106666 - Abelson; Mark Barry ; et al. | 2016-04-21 |
Ophthalmic formulations of cetirizine and methods of use
Grant 9,254,286 - Abelson , et al. February 9, 2 | 2016-02-09 |
Topical Ophthalmic Formulations for the Treatment and Prevention of Migraine Headache
App 20140343041 - Chapin; Matthew J. ; et al. | 2014-11-20 |
Ophthalmic formulations of cetirizine and methods of use
Grant 8,829,005 - Abelson , et al. September 9, 2 | 2014-09-09 |
Compositions for the Treatment and Prevention of Eyelid Swelling
App 20140161903 - Chapin; Matthew J. ; et al. | 2014-06-12 |
Ophthalmic Formulations Of Cetirizine And Methods Of Use
App 20140045803 - Abelson; Mark Barry ; et al. | 2014-02-13 |
Ophthalmic formulations of cetirizine and methods of use
Grant 8,569,273 - Abelson , et al. October 29, 2 | 2013-10-29 |
Ophthalmic Formulations of Cetirizine and Methods of Use
App 20130252971 - Abelson; Mark Barry ; et al. | 2013-09-26 |
Ophthalmic Formulations, Methods Of Manufacture And Methods of Normalizing Meibomian Gland Secretions
App 20120093876 - Ousler, III; George W. ; et al. | 2012-04-19 |
Ophthalmic Formulations Of Cetirizine And Methods Of Use
App 20110257136 - Abelson; Mark B. ; et al. | 2011-10-20 |
Ophthalmic Formulations Of Fluticasone And Methods Of Use
App 20110105450 - Chapin; Matthew J. ; et al. | 2011-05-05 |
Ophthalmic Formulations, Methods Of Manufacture, And Methods Of Using Same
App 20100311688 - Chapin; Matthew J. ; et al. | 2010-12-09 |
Ophthalmic Formulations of Cetirizine and Methods of Use
App 20100240625 - Abelson; Mark B. ; et al. | 2010-09-23 |
Ophthalmic Formulations of Ketotifen and Methods of Use
App 20100240624 - Chapin; Matthew J. ; et al. | 2010-09-23 |
Formulations and Methods for Treating Dry Eye
App 20100130580 - Ousler, III; George W. ; et al. | 2010-05-27 |
Formulations and methods for treating dry eye
App 20090010850 - Ousler, III; George W. ; et al. | 2009-01-08 |
Methods and compositions for normalizing meibomian gland secretions
App 20080312194 - Ousler, III; George W. ; et al. | 2008-12-18 |
Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
App 20080261890 - Ousler; George W. ; et al. | 2008-10-23 |
Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
App 20060270592 - Ousler; George W. III ; et al. | 2006-11-30 |
Novel topical ophthalmic formulations
App 20050239745 - Abelson, Mark B. ; et al. | 2005-10-27 |
Combinational use of long-acting and short-acting anti-histamines for ocular allergies
App 20040198828 - Abelson, Mark B. ; et al. | 2004-10-07 |
| 